FDA Approved: EGRIFTA WR — Original Application (Theratechnologies Inc.)

View source ↗

Summary

FDA approved EGRIFTA WR (tesamorelin) from Theratechnologies Inc. through an original application. It is indicated for HIV-associated lipodystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Lipodystrophy

Drugs mentioned

• EGRIFTA WR (TESAMORELIN)

Snippet

ORIG AP for EGRIFTA WR (TESAMORELIN)